Takeda Pharmaceutical Co Ltd
TSE:4502
Takeda Pharmaceutical Co Ltd
Selling, General & Administrative
Takeda Pharmaceutical Co Ltd
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Selling, General & Administrative
-¥1T
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-9%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Selling, General & Administrative
-¥578.3B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-9%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Selling, General & Administrative
-¥807.4B
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
Eisai Co Ltd
TSE:4523
|
Selling, General & Administrative
-¥356.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Selling, General & Administrative
-¥111.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-3%
|
|
Astellas Pharma Inc
TSE:4503
|
Selling, General & Administrative
-¥907.6B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
-15%
|
See Also
What is Takeda Pharmaceutical Co Ltd's Selling, General & Administrative?
Selling, General & Administrative
-1T
JPY
Based on the financial report for Dec 31, 2023, Takeda Pharmaceutical Co Ltd's Selling, General & Administrative amounts to -1T JPY.
What is Takeda Pharmaceutical Co Ltd's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-9%
Over the last year, the Selling, General & Administrative growth was -6%. The average annual Selling, General & Administrative growth rates for Takeda Pharmaceutical Co Ltd have been -5% over the past three years , -11% over the past five years , and -9% over the past ten years .